Table 2.

Women reporting individual adverse outcomes expressed as number (and percentage of 200 women in this overall group)

Adverse outcome	Number of women (%) reporting symptoms Total n = 200
Significant overall bowel symptoms	75 (38%)
Flatal incontinence or fecal urgency (“sometimes” or more)	67 (34%)
Fecal incontinence (“occasionally” or more)	38 (19%)
Impact on daily life indicated in three or more reported areas	73 (37%)
Higher than average level of sexual dysfunction score (> 5.04)	20 (10%)

These Adverse Outcomes formed the components of the OASIACO